Los Angeles Times (Home Edition), Wednesday July 9, 1997 Page D-3
Denise Gellene; Times Staff Writer

The two-minute spots premiered on three cable TV networks and on local stations in Nashville; Kansas City, Mo.; Seattle; and Columbus, Ohio. The campaign is considered a test and will last three weeks.

Broadcasters have been skittish about birth control ads, and Pharmacia & Upjohn encountered resistance in getting its commercials on the air. The company said a number of stations rejected the ads, citing policies against birth control advertising. Many of the stations that agreed to run the spots have relegated them to hours when children aren't likely to see them.

WDAF-TV, the Fox Broadcasting affiliate in Kansas City, said it agreed to air the spots only after 10:30 p.m.

"Obviously, we are trying to put it in at a time period when the primary viewing audience is adults," said WDAF General Manager Ed Piette.

Depo-Provera is administered by injection four times a year. Though it costs about the same as oral contraceptives, it is not nearly as popular as the Pill. The company said Depo-Provera, introduced in 1992, accounts for about 7% of the $1-billion domestic birth control market.

James Trussell, director of the office of population research at Princeton University, said Depo-Provera is used more by younger women and teenagers. He said government statistics show that 7.9% of women between the ages of 15 and 19 use Depo-Provera, compared with 3.9% of women between the ages of 24 and 29.

Pharmacia & Upjohn said its commercials target women 18 to 44.

Trussell applauded the advertising, saying "it would create awareness of the options available to women."

But it is certain to upset religious groups that oppose birth control. Advertisers accept public service ads that promote condom use, but they have been reluctant to accept paid advertising for condoms or other birth control methods.

The company is using three commercials to target different groups of women. One spot features an unmarried woman, another shows a young mother, and the third focuses on an older woman who has completed her family. The commercials, shot home-video style, show the women at family gatherings where they describe their plans about having children. The ads carry the tagline: "Be sure of your plans. Be sure of your birth control."

Besides the local stations, the ads appear on USA Network and its sister channel, the Sci-Fi Network, and on Black Entertainment Television. Joan Sinopoli, vice president of Pharmacia & Upjohn's advertising agency, HMC Consumer, said usage of Depo-Provera is greater among black women than in the general female population. That audience has been a lucrative one for the company, she said.

Depo-Provera has a controversial history. Women's groups have debated its use because inconclusive research links it to bone loss, a cause of osteoporosis. The National Women's Health Network, a Washington-based advocacy group, contends that the contraceptive is being prescribed to minority women, sometimes against their will. It has asked the Food and Drug Administration to require doctors to obtain written consent from patients before prescribing long-term contraceptives.

Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .